Company intelligence / Profile preview

Innovaoleo

Ownership: Private
Employees: ~13
Development stage: Commercial

Overview

Innovaoleo operates as the Omega 3 division of Natac Group. It focuses on biotechnology research and production of food products and pharmaceuticals derived from omega fatty acids. No clinical trial results or pharmaceutical pipeline data available.

Therapeutic areas: Metabolic DisordersCardiovascularOther
Modalities: Nutraceutical ingredient(s)Small molecule
Industry: Chemicals & Materials

Partnerships

Parent company relationship with Natac GroupNo major pharma/biotech partnerships disclosed publicly.

Beyond the preview

Go deeper on Innovaoleo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovaoleo.

Explore the full profile